Oral Clinical Nutrition Supplement Market: Projected Growth to Reach US$ 19613.1 Million by 2033

 

Oral Clinical Nutrition Supplement Market

 

The global oral clinical nutrition supplement market supplements is anticipated to grow from US$ 10,788.70 million in 2023 to US$ 19,613.1 million by 2033. The market is expected to grow positively throughout the projected period, with a compound yearly growth rate of 6.2%.

It is projected that the oral clinical nutrition supplement market will expand quickly, reaching over US$ 19.6 billion in 2033 from $10.8 billion in 2023. These supplements are becoming more and more crucial, particularly in the treatment of malnourishment, the aiding of long-term sick patients, and maintaining a robust immune system. Since drawing customers is still important, new preferences are developing.

Oral clinical nutrition supplements are expected to have a US$ 19,613.1 million market by 2033, up from US$ 10,788.70 million in 2023. The market is expected to grow positively throughout the projected period, with a compound yearly growth rate of 6.2%.

Based on projections, the global market for oral clinical nutrition supplements is expected to rise at a powerful compound annual growth rate (CAGR) of 6.2%, rising from US$ 10,788.70 million in 2023 to an astounding US$ 19,613.1 million by 2033.

Unlock Growth Potential in Your Industry – Get Your Sample Report Now!
https://www.futuremarketinsights.com/reports/sample/rep-gb-9486

These supplements are becoming increasingly important, notably in the treatment of malnutrition and in the care of patients suffering from chronic illnesses. The requirement to maintain a robust immune system drives market dynamics even further, with new and unique flavours appearing to entice customers.

The market for oral therapeutic nutrition supplements has increased significantly, driven by a focus on immune system fortification. This tendency is expected to continue, creating an increased need for these supplements in the coming years. Notably, their involvement in treating malnutrition is projected to have a significant impact on market growth.

For patients facing challenges in consuming regular meals due to taste loss resulting from ongoing infections, oral clinical nutrition supplements prove to be valuable. In a bid to attract customers and sustain market expansion, many manufacturers are actively developing innovative flavors, which remain crucial for market growth.

Key Takeaways from Market Study:

1.     Market Growth: The oral clinical nutrition supplement market is expected to achieve a commendable CAGR of 6.2% over the forecast period.

2.     Regional Strength: North America is anticipated to maintain robust market strength during the forecast period.

3.     Formulation Innovation: The introduction of oral clinical nutrition formulas in liquid form is expected to contribute significantly to market growth, boasting a CAGR of 7.2%.

4.     Flavor Preferences: Flavored oral clinical nutrition supplements are projected to dominate the market, holding a substantial market share of 70%.

5.     Geographic Expansion: The United States is poised for substantial market growth by 2033.

6.     Distribution Channels: Prescription-based channels are anticipated to account for over 90% of oral clinical nutrition supplement sales.

Competitive Background:

Leading players in the market are actively engaged in various consolidation activities, including mergers, acquisitions, supply distribution partnerships, and product launches. Manufacturers are strategically expanding their market footprint and offering tailored solutions to cater to a variety of end-user preferences.

Several prominent companies dominate this market, including NUTRICIÓN MÉDICA SL, Meiji Holdings Co., Ltd., Medtrition Inc., Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Mead Johnson & Company, LLC, Otsuka Holdings Co., Ltd., Abbott Laboratories, Danone Nutricia, Victus, Inc., Cambrooke Therapeutics, Inc., GlaxoSmithKline plc, Nestlé S.A., Kate Farms, Inc., Perrigo Company plc, Sichuan Kelun Pharmaceutical Co., Ltd., AYMES International Ltd., Pfizer Inc., Medifood GmbH, Nature’s Bounty Inc., Pharmavite LLC., and others.

Recent Developments:

1.     Ensure Harvest and PediaSure Harvest were relaunched in September 2021 with plant-based protein and organic ingredients, offering versatile nutrition solutions.

2.     Nestlé Health Science acquired Persona, a firm specializing in personalized vitamins, in August 2019, presenting an opportunity for expanded personalized nutrition services.

3.     In February 2019, Matok V’Kal introduced a stamina boost-up spray with only six calories and no caffeine.

4.     PRO-DIP introduced a revolutionary pouch with small, semi-permeable sachets of energy and nutrition through its new oral clinical nutritional supplement in April 2019.

5.     In April 2018, Abbott launched Ensure Max, a nutritional drink with high-quality proteins and very low sugar content.

The demand for oral therapeutic nutrition supplements has increased as a result of the emphasis on keeping a strong immune system. It is anticipated that there would be a growing need for oral therapeutic nutrition supplements in the coming years. It has the potential to have a significant impact on the market development for oral clinical nutrition supplements due to its use in the treatment of malnutrition. Clinical nutrition supplements that are taken orally may be beneficial for patients with chronic illnesses or those who are undernourished.

Oral clinical nutrition supplements may be useful for patients who have difficulty eating regular meals due to a loss of taste brought on by an ongoing infection. Innovative flavours are being developed by many producers of oral medicinal nutrition supplements in an effort to attract customers. This might still be essential for the market to expand.

A few of the key factors projected to drive the growth of the oral clinical nutrition supplements market include the rising demand for healthy meals, the rise in the number of young people, and the growing preference for a variety of oral clinical nutrition supplements among the general public.

“Chronic infections are on the rise, healthcare expenditures are increasing, and there are projected to be more global competitors in the food processing industry. Also, a significant demand for oral clinical nutrition supplements is anticipated as healthcare expenditures increase.”– -says Nandini Roy Choudhury (client Partner for Food and Beverages at  Future Market Insights, Inc.)

Key Takeaways from Market Study

  • The oral clinical nutrition supplement market is expected to record a CAGR of 6.2% over the forecast period.
  • It is estimated that the oral clinical nutrition supplement market in North America may remain strong during the forecast period.
  • The launch of oral clinical nutrition formulas in liquid form may continue aiding growth in the form segment with a CAGR of 7.2%
  • Flavored oral clinical nutrition supplements are likely to hold a market share of 70%.
  • It is expected that the market in the United States may demonstrate a high level of growth by 2033.
  • Prescription-based channels are likely to be responsible for more than 90% of sales of oral clinical nutrition supplements.

Competitive Background:

Leading players in the market focus on a variety of market consolidation activities, including mergers, acquisitions, supply distribution partnerships, and product launches. In order to be successful, manufacturers must expand their market footprint and offer solutions to their customers. A variety of end users can now choose from a wide range of customized solutions offered by leading manufacturers.

Drive Your Growth Strategy: Purchase the Report for Key Insights!
https://www.futuremarketinsights.com/checkout/9486

Recent Developments:

  • Ensure Harvest and PediaSure Harvest were relaunched in September 2021 with plant-based protein and organic ingredients. As a source of nutrition or as a means of meeting a person’s daily nutritional needs, hence nutritional supplements can be used in many ways.
  • Persona, a firm that offers personalized vitamins, has been acquired by Nestlé Health Science in August 2019. The company has the opportunity to expand its personalized nutrition services.
  • With only six calories and no caffeine, Matok V’Kal launched a stamina boost-up spray in February 2019.
  • With the introduction of PRO-DIP’s new oral clinical nutritional supplement in April 2019, PRO-DIP introduced a revolutionary pouch that provides small, semi-permeable sachets of energy and nutrition.
  • In April 2018, Abbott introduced Ensure Max, which is a nutritional drink with high-quality proteins and very low sugar content.

Oral Clinical Nutrition Supplement Market Segmentation by Category

Product Type:

  • Standard Formula
  • Specialized Formula

Indication:

  • General Well-being
  • Renal Disorders
  • Hepatic Disorders
  • Oncology Nutrition
  • Diabetes
  • Dysphagia
  • IBD & GI Tract Disorders
  • Neurological Disorders
  • Respiratory Orders
  • Others

Form:

  • Liquid
  • Semi-solid
  • Powder

End User:

  • Adult
  • Geriatric
  • Pediatric

Flavor:

  • Regular
  • Flavored
    • Chocolate
    • Vanilla
    • Strawberry
    • Apple
    • Mixed Berries
    • Orange
    • Nut Flavours

Channel:

  • Prescription-based
  • Over-the-Counter
    • Modern Trade
    • Hospital Pharmacies
    • Retail Pharmacies
    • Drug Stores
    • Online Pharmacies

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: 
sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

About the Author

Nikhil Kaitwade

Associate Vice President at Future Market Insights, Inc. has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.
His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.
Nikhil holds an MBA degree in Marketing and IT and a Graduate in Mechanical Engineering. Nikhil has authored several publications and quoted in journals like EMS Now, EPR Magazine, and EE Times.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these